Norovirus and medically attended gastroenteritis in U.S. children

New England Journal of Medicine

Volumn 368, Issue 12, 2013, Pages 1121-1130

  Payne, Daniel C ^a   Vinjé, Jan ^a   Szilagyi, Peter G ^b   Edwards, Kathryn M ^c   Staat, Mary Allen ^e   Weinberg, Geoffrey A ^b   Hall, Caroline B ^b   Chappell, James ^c,d   Bernstein, David I ^e   Curns, Aaron T ^a   Wikswo, Mary ^a   Shirley, S Hannah ^a,f   Hall, Aron J ^a   Lopman, Benjamin ^a   Parashar, Umesh D ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GASTROENTERITIS; ARTICLE; CHILD; CHILD HOSPITALIZATION; CONTROLLED STUDY; DISEASE SURVEILLANCE; EMERGENCY WARD; ENZYME IMMUNOASSAY; FECES ANALYSIS; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; NOROVIRUS INFECTION; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; ROTAVIRUS INFECTION; UNITED STATES; VIRUS DETECTION;

EID: 84875188927     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMsa1206589     Document Type: Article

References (29)

1. Glass RI, Parashar UD, Estes MK. Norovirus gastroenteritis. N Engl J Med 2009;361:1776-85.
2. Hall AJ, Rosenthal M, Gregoricus N, et al. Incidence of acute gastroenteritis and role of norovirus, Georgia, USA, 2004-2005. Emerg Infect Dis 2011;17:1381-8.
3. Yen C, Wikswo ME, Lopman BA, Vinje J, Parashar UD, Hall AJ. Impact of an emergent norovirus variant in 2009 on norovirus outbreak activity in the United States. Clin Infect Dis 2011;53:568-71.
4. Tate JE, Panozzo CA, Payne DC, et al. Decline and change in seasonality of US rotavirus activity after the introduction of rotavirus vaccine. Pediatrics 2009;124:465-71.
5. Reduction in rotavirus after vaccine introduction - United States, 2006-2009. MMWR Morb Mortal Wkly Rep 2009;58:1146-9.
6. Tate JE, Cortese MM, Payne DC, et al. Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J 2011;30:Suppl:S56-S60.
7. Payne DC, Staat MA, Edwards KM, et al. Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US counties, 2006-2009. Clin Infect Dis 2011;53:245-53.
8. Cortese MM, Tate JE, Simonsen L, Edelman L, Parashar UD. Reduction in gastroenteritis in United States children and correlation with early rotavirus vaccine uptake from national medical claims databases. Pediatr Infect Dis J 2010;29:489-94.
9. Frey S, Treanor JJ, Atmar RL, et al. Phase 1 dosage escalation, safety and immunogenicity study of a bivalent norovirus VLP vaccine by the intramuscular route. Presented at the 49th Annual Meeting of the Infectious Disease Society of America, Boston, October 20, 2011.
10. Vesikari T, Lappalainen S, Nurminen K, et al. Development of a combined norovirus-rotavirus vaccine. Presented at the 6th International Vaccines for Enteric Diseases Conference, Cannes, France, September 15, 2011.
11. Atmar RL, Bernstein DI, Harro CD, et al. Norovirus vaccine against experimental human Norwalk virus illness. N Engl J Med 2011;365:2178-87.
12. El-Kamary SS, Pasetti MF, Mendelman PM, et al. Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis 2010;202:1649-58. [Erratum, J Infect Dis 2011;203:1036.]
13. Payne DC, Staat MA, Edwards KM, et al. Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics 2008;122:1235-43.
14. Vega E, Barclay L, Gregoricus N, Williams K, Lee D, Vinjé J. Novel surveillance network for norovirus gastroenteritis outbreaks, United States. Emerg Infect Dis 2011;17:1389-95.
15. Payne DC, Szilagyi P, Staat MA, et al. Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J 2009;28:948-53.
16. Poehling KA, Edwards KM, Weinberg GA, et al. The underrecognized burden of influenza in young children. N Engl J Med 2006;355:31-40.
17. Tate JE, Mutuc JD, Panozzo CA, et al. Sustained decline in rotavirus detections in the United States following the introduction of rotavirus vaccine in 2006. Pediatr Infect Dis J 2011;30:Suppl:S30-S34.
18. Zheng DP, Widdowson MA, Glass RI, Vinjé J. Molecular epidemiology of genogroup II-genotype 4 noroviruses in the United States between 1994 and 2006. J Clin Microbiol 2010;48:168-77.
19. Pitzer VE, Viboud C, Simonsen L, et al. Demographic variability, vaccination, and the spatiotemporal dynamics of rotavirus epidemics. Science 2009;325:290-4.
20. Atchison C, Lopman B, Edmunds WJ. Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales. Vaccine 2010;28:3118-26.
21. Kilgore A, Donauer S, Edwards KM, et al. Medical costs of rotavirus-associated hospitalizations and emergency department visits. Vaccine (in press).
22. Mast TC, Walter EB, Bulotsky M, et al. Burden of childhood rotavirus disease on health systems in the United States. Pediatr Infect Dis J 2010;29(2):e19-e25.
23. Lopman BA, Hall AJ, Curns AT, Parashar UD. Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis 2011;52:466-72.
24. Patel MM, Widdowson MA, Glass RI, Akazawa K, Vinjé J, Parashar UD. Systematic literature review of the role of noroviruses in sporadic gastroenteritis. Emerg Infect Dis 2008;14:1224-31.
25. Chan MC, Sung JJ, Lam RK, et al. Fecal viral load and norovirus-associated gastroenteritis. Emerg Infect Dis 2006;12:1278-80.
26. Lee N, Chan MC, Wong B, et al. Fecal viral concentration and diarrhea in norovirus gastroenteritis. Emerg Infect Dis 2007;13:1399-401. (Pubitemid 47510311)
27. Desai R, Hembree CD, Handel A, et al. Severe outcomes are associated with genogroup 2 genotype 4 norovirus outbreaks: a systematic literature review. Clin Infect Dis 2012;55:189-93.
28. Lindesmith LC, Donaldson EF, Lobue AD, et al. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med 2008;5(2):e31.
29. van Beek J, Ambert-Balay K, Botteldoorn N, et al. Indications for worldwide increased norovirus activity associated with emergence of a new variant of genotype II.4, late 2012. Euro Surveill 2013;18 (http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20345).